| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.007 |
| mRNA |
IOX2 |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.007 |
| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.14 |
0.007 |
| mRNA |
ruxolitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.007 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.008 |
| mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.009 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.01 |
| mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.01 |
| mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.01 |
| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.01 |